Steven  Threlkeld

Steven Threlkeld


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JMJohn Marshall
John Marshall
JSJoanna Szmydynger-Chodobska
Joanna Szmydynger-Chodobska
MRMengia S. Rioult-Pedotti
Mengia S. Rioult-Pedotti
KLKara Lau
Kara Lau
ACAndrea T. Chin
Andrea T. Chin
ACAdam Chodobski
Adam Chodobski
Brain-derived neurotrophic factor (BDNF), a key player in regulating synaptic strength and learning, is dysregulated following traumatic brain injury (TBI), suggesting that stimulation of BDNF signaling pathways may facilitate functional recovery. This study investigates whether CN2097, a peptidomimetic ligand which targets the synaptic scaffold protein, postsynaptic density protein 95, to enhance downstream signaling of tropomyosin-related kinase B, a receptor for BDNF, can improve neurological function after TBI. Moderate to severe TBI elicits neuroinflammation and c-Jun-N-terminal kinase (JNK) activation, which is associated with memory deficits. Here we demonstrate that CN2097 significantly reduces the post-traumatic synthesis of proinflammatory mediators and inhibits the post-traumatic activation of JNK in a rodent model of TBI. The recordings of field excitatory post-synaptic potentials in the hippocampal CA1 subfield demonstrate that TBI inhibits the expression of long-term potentiation (LTP) evoked by high-frequency stimulation of Schaffer collaterals, and that CN2097 attenuates this LTP impairment. Lastly, we demonstrate that CN2097 significantly improves the complex auditory processing deficits, which are impaired after injury. The multifunctionality of CN2097 strongly suggests that CN2097 could be highly efficacious in targeting complex secondary injury processes resulting from neurotrauma.

1 August 2017 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
STSteven Threlkeld
Steven Threlkeld
YLYow-Pin Lim
Yow-Pin Lim
MRMolly La Rue
Molly La Rue
CGCynthia Gaudet
Cynthia Gaudet
Barbara S StonestreetBarbara S Stonestreet
Barbara S Stonestreet

7 June 2018 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CDClemence Disdier
Clemence Disdier
XCXiaodi Felix Chen
Xiaodi Felix Chen
JKJeong-Eun Kim
Jeong-Eun Kim
STSteven Threlkeld
Steven Threlkeld
Barbara S StonestreetBarbara S Stonestreet
Barbara S Stonestreet
Perinatal brain injury is a major cause of morbidity and long-standing disability in newborns. Hypothermia is the only therapy approved to attenuate brain injury in the newborn. However, this treatment is unfortunately only partially neuroprotective and can only be used to treat hypoxic-ischemic encephalopathy in full term infants. Therefore, there is an urgent need for adjunctive therapeutic strategies. Post-ischemic neuro-inflammation is a crucial contributor to the evolution of brain injury in neonates and constitutes a promising therapeutic target. Recently, we demonstrated encouraging neuroprotective capacities of anti-cytokine monoclonal antibodies (mAbs) in an ischemic-reperfusion (I/R) model of brain injury in the ovine fetus. The purpose of this review is to summarize the current knowledge regarding the inflammatory response in the perinatal sheep brain after I/R injury and to review our recent findings regarding the beneficial effects of treatment with anti-cytokine mAbs.

17 December 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ABAaron Bradford
Aaron Bradford
MHMiranda Hernandez
Miranda Hernandez
EKElaine Kearney
Elaine Kearney
LTLuke Theriault
Luke Theriault
Yow-Pin LimYow-Pin Lim
Yow-Pin Lim
STSteven Threlkeld
Steven Threlkeld
Hypoxic-Ischemic (HI) brain injury in the neonate contributes to life-long cognitive impairment. Early diagnosis and therapeutic interventions are critical but limited. We previously reported in a rat model of HI two interventional approaches that improve cognitive and sensory function: administration of Inter-alpha Inhibitor Proteins (IAIPs) and early experience in an eight-arm radial water maze (RWM) task. Here, we expanded these studies to examine the combined effects of IAIPs and multiple weeks of RWM assessment beginning with juvenile or adolescent rats to evaluate optimal age windows for behavioral interventions. Subjects were divided into treatment groups; HI with vehicle, sham surgery with vehicle, and HI with IAIPs, and received either juvenile (P31 initiation) or adolescent (P52 initiation) RWM testing, followed by adult retesting. Error rates on the RWM decreased across weeks for all conditions. Whereas, HI injury impaired global performance as compared to shams. IAIP-treated HI subjects tested as juveniles made fewer errors as compared to their untreated HI counterparts. The juvenile group made significantly fewer errors on moderate demand trials and showed improved retention as compared to the adolescent group during the first week of adult retesting. Together, results support and extend our previous findings that combining behavioral and anti-inflammatory interventions in the presence of HI improves subsequent learning performance. Results further indicate sensitive periods for behavioral interventions to improve cognitive outcomes. Specifically, early life cognitive experience can improve long-term learning performance even in the presence of HI injury. Results from this study provide insight into typical brain development and the impact of developmentally targeted therapeutics and task-specific experience on subsequent cognitive processing.

6 May 2022 in Neurotrauma Reports
Verified
Journal Article
Open access
STSteven Threlkeld
Steven Threlkeld
ECEmma Morales Cestero
Emma Morales Cestero
JMJohn Marshall
John Marshall
JSJoanna Szmydynger-Chodobska
Joanna Szmydynger-Chodobska
ACAdam Chodobski
Adam Chodobski
Traumatic brain injury (TBI) exacts significant neurological and financial costs on patients and their families. In adult patients with moderate-to-severe TBI, central auditory impairments have been reported. These auditory impairments may interfere with language receptivity, as observed in children with developmental brain injury. Although rodent models of TBI have been widely used to examine behavioral outcomes, few studies have evaluated how TBI affects higher-order central auditory processing across a range of cue complexities. Here, auditory processing was assessed using a modified acoustic startle paradigm. We used a battery of progressively complex stimuli (single-tone, silent gaps in white noise, and frequency-modulated [FM] sweeps) in adult rats that received unilateral controlled cortical impact injury. TBI subjects showed significant reductions in acoustic startle absolute responses across nearly all stimuli, regardless of cue, duration of stimuli, or cue complexity. Despite this overall reduction of startle magnitudes in injured animals, the detection of single-tone stimuli was comparable between TBI and sham-injured subjects, indicating intact hearing after TBI. TBI subjects showed deficits in rapid gap (5 ms) and FM sweep (175 ms) detection, and, in contrast to shams, they did not improve on detecting silent gaps and FM sweeps across days of testing. Our findings provide evidence for both low-level (brainstem-mediated) and higher-order central auditory processing deficits in a rodent model of TBI, which parallel sensory impairments observed in TBI patients. The present findings support the use of modified pre-pule auditory detection paradigms to investigate clinically relevant processes in TBI.

1 September 2019 in Translational Issues in Psychological Science
Verified
Journal Article
Closed access
STSteven Threlkeld
Steven Threlkeld
SMStephanie Maddox
Stephanie Maddox
BJBrielle T. James
Brielle T. James
EJEliza Jacobs-Brichford
Eliza Jacobs-Brichford